Drawing for QUESTCOR

USPTO serial 75867216

QUESTCOR

Reviewed by CopyMark Law Group

Reg. 2756559Status 710
Filing date
Status date
Registration date
Aug 26, 2003
Examiner
TINGLEY, JOHN
Law office
GENERIC WEB UPDATE

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with QUESTCOR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

F.T. Alexandra Mahaney

Questcor Pharmaceuticals, Inc.26118 Research RoadHayward, CA 94545UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005house mark for a full line of pharmaceutical products, specifically excluding products in the field of bone grafting or bone regeneration or related productsSECTION 8 - CANCELLEDNov 17, 1999
035[ pharmaceutical supply, namely, distributionships in the field of pharmaceuticals but excluding those in the field of bone grafting or bone regeneration or related products or services ]SECTION 8 - CANCELLEDNov 17, 1999
040[ manufacture of general product lines in the field of pharmaceuticals to the order and specification of others and consultancy and advisory services relating thereto, specifically excluding the field of bone grafting or bone regeneration or related products and services ]SECTION 8 - CANCELLEDNov 17, 1999
042Pharmaceutical and life science research and development and consultancy and advisory services relating thereto, specifically excluding services in the field of bone grafting or bone regenerationSECTION 8 - CANCELLEDNov 17, 1999

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 8, 2024CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
Nov 22, 2023ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Aug 26, 2022REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Jul 13, 2022ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Jul 31, 2019ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Aug 27, 2014ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Aug 28, 2013NA89NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED—
Aug 28, 2013RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Aug 28, 201389AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Aug 19, 201389AFREGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED—
Aug 19, 2013E89RTEAS SECTION 8 & 9 RECEIVED—
Aug 19, 2013TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 28, 2009C15PREGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Aug 25, 2009PLGLASSIGNED TO PARALEGAL—
Aug 21, 2009815FREGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED—
Aug 21, 2009E815TEAS SECTION 8 & 15 RECEIVED—
Jul 21, 2008CFITCASE FILE IN TICRS—
Aug 16, 2006COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Aug 10, 2006PLGLASSIGNED TO PARALEGAL—
Jul 24, 2006MAILPAPER RECEIVED—
Aug 26, 2003R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 27, 2003CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
May 7, 2003MAILPAPER RECEIVED—
May 5, 2003SUPCSTATEMENT OF USE PROCESSING COMPLETE—
May 5, 2003IUAFUSE AMENDMENT FILED—
Nov 5, 2002NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 4, 2002OP.TOPPOSITION TERMINATED NO. 999999—
Sep 4, 2002OP.DOPPOSITION DISMISSED NO. 999999—
Apr 16, 2002OP.DOPPOSITION DISMISSED NO. 999999—
Jul 24, 2001OP.IOPPOSITION INSTITUTED NO. 999999—
Mar 26, 2001OPPFOPPOSITION PAPERS RECEIVED AT TTAB—
Feb 27, 2001PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 26, 2001NPUBNOTICE OF PUBLICATION—
Dec 5, 2000CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 21, 2000DOCKASSIGNED TO EXAMINER—
May 24, 2000CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 17, 2000DOCKASSIGNED TO EXAMINER—
May 2, 2000DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance